Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Oxidative stress and myocardial gene alterations associated with doxorubicin-induced cardiotoxicity in rats persist for two months after treatment cessation

Abstract : The molecular mechanisms underlying doxorubicin (DOX)-induced cardiomyopathy include alterations in cardiomyocytes' oxidative stress status and in gene expression. Although such alterations have been reported during in vivo DOX treatment of animals, it remains to be clarified whether they persist after treatment cessation. To address this question, rats were injected with either saline (1 ml/kg/day i.p; control) or DOX (1 mg/kg/day i.p.) for 10 days, and 70 days later cardiac functional parameters were evaluated in vivo by left ventricular catheterization. Hearts were also harvested for histological analyses as well as measurements of oxidative stress parameters by various techniques and gene expression by quantitative polymerase chain reaction of markers of cardiac pathological remodeling, namely atrial natriuretic factor, myosin heavy chain β, vascular endothelial growth factor A (VEGF-A), and sarcoplasmic reticulum Ca(+2) ATPase. Compared with controls, DOX-treated rats displayed marked alterations in most parameters even 2 months after cessation of treatment. These included 1) lower left ventricular contractility (+dP/dt), 2) increased levels of plasma and myocardial oxidative stress markers, namely thiobarbituric acid reactive substances or dihydroethidium fluorescence, and 3) markedly altered transcript levels for all measured markers of cardiac remodeling, except VEGF-A. These changes correlated significantly with +dP/dt values assessed in the two groups of animals. In conclusion, this study demonstrated that as many as 2 months after cessation of DOX treatment cardiac alterations persisted, reflecting increased oxidative stress and pathological remodeling, the latter being linked to the development of contractile dysfunction.
Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-03435401
Contributeur : Catherine Vergely Connectez-vous pour contacter le contributeur
Soumis le : jeudi 18 novembre 2021 - 17:00:33
Dernière modification le : samedi 11 décembre 2021 - 03:45:44

Identifiants

Collections

Citation

Carole Richard, Steliana Ghibu, Stéphanie Delemasure-Chalumeau, Jean-Claude Guilland, Christine Des Rosiers, et al.. Oxidative stress and myocardial gene alterations associated with doxorubicin-induced cardiotoxicity in rats persist for two months after treatment cessation. Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2011, 339 (3), pp.807-814. ⟨10.1124/jpet.111.185892⟩. ⟨hal-03435401⟩

Partager

Métriques

Les métriques sont temporairement indisponibles